The company's performance appears satisfactory, particularly its high reinvestment rate from profits and strong ROE contributing to a respectable growth in earnings. The latest industry analyst forecasts reveal that the company's earnings are expected to accelerate.
SMO Clinplus Stock Forum
No comment yet